Day: January 6, 2022

New York Becomes Largest State with DraftKings Mobile Sportsbook BOSTON and NEW YORK, Jan. 06, 2022 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) today announced the company will launch its mobile and online sportsbook in New York on Saturday, January 8. The Company is set to become one of the first operators to launch in the Empire State. The launch comes ahead of the NFL Playoffs, one of the busiest periods for betting activity in the year. The State authorized mobile and online sports betting in New York this past April. “We are excited to finally be able to offer millions of passionate New York sports fans the top rated DraftKings mobile and online Sportsbook,” said Jason Robins, CEO, co-founder and chairman of the board, DraftKings. “We want to extend a special thanks to Governor Hochul, Senator Addabbo, Assemblyman Pretlow,...

TORONTO, Jan. 06, 2022 (GLOBE NEWSWIRE) — Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”) is pleased to announce that it has today filed a final short form base shelf prospectus with the securities commissions in each of the provinces and territories of Canada, except Québec. The base shelf prospectus (the “Shelf Prospectus”) allows Patriot One to offer and issue up to $50 million of common shares, warrants, subscription receipts, units, debt securities, or any combination of such securities (collectively, the “Securities”) during the 25-month period that the Shelf Prospectus is effective. The Securities may be offered separately or together, in amounts, at prices and on terms to be determined based on market conditions at the time of sale, which will be set forth in a prospectus...

Company Management Available for 1×1 Meetings Concurrent with the 40th Annual J.P. Morgan Healthcare Conference January 10-14 BOCA RATON, Fla. , Jan. 06, 2022 (GLOBE NEWSWIRE) — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that Joe Sardano, chairman and chief executive officer, will present at the H.C. Wainwright BioConnect Virtual Conference being held January 10-13, 2022.  A pre-recorded presentation will be available on demand beginning Monday, January 10 at 7:00 a.m. Eastern time. Interested parties can access the presentation on the investor relations section of the Company’s website and at this link. Also, Sensus management is holding virtual 1×1...

JERSEY CITY, N.J., Jan. 06, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that Marco Taglietti, M.D., President and Chief Executive Officer of SCYNEXIS, will present during two virtual investor conferences in January. Presentation details:LifeSci Partners 11th Annual Corporate Access EventFormat: Virtual panel discussion with CEO and 1:1 meetingsPanel Title: The Best of Both Worlds – Defining Yourself When You Fit into More Than One BasketDate and Time: Friday, January 7, at 10:00 a.m. ETRegistration link: LifeSci Partners Corporate Access Event 2022H.C. Wainwright Bioconnect 2022 Virtual Healthcare ConferenceFormat: Virtual event with webcast of corporate update presentation...

HOUSTON, Jan. 06, 2022 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today that the company will present at H.C. Wainwright BioConnect and participate in Biotech Showcase and BIO Partnering @ JPM. All three events will be held virtually and are scheduled alongside the J.P. Morgan 40th Annual Healthcare Conference 2022. Details of the events are as follows:Event:   Biotech ShowcaseDate:    January 10-12, 2022Registration:   https://informaconnect.com/biotech-showcase/registration-options/     Event:   H.C. Wainwright BioConnectDate:   January 10-13, 2022Registration:   https://hcwevents.com/bioconnect     Event:   BIO Partnering @ JPMDate:    January...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 06, 2022 (GLOBE NEWSWIRE) — G2 Goldfields Inc. (“G2” or the “Company”) (TSXV:GTWO; OTCQX:GUYGF) announces that it has closed the first tranche (the “First Tranche”) of its previously announced non-brokered private placement (the “Offering”). In connection with the closing of the First Tranche, the Company sold 2,250,000 units of the Company (the “Units”) at a price of $0.45 per Unit, for gross proceeds of $1,012,500. Each Unit consisted of one common share (“Share”) of the Company and one common share purchase warrant (“Warrant”). Each Warrant entitles the holder, on exercise, to purchase one Share for a period of two years following the closing date of First Tranche at an exercise price of $1.20 per Share. The entire First Tranche...